Latest NewsGlenmark Pharma signs agreement with SeqirusadminJuly 6, 2018 July 6, 2018 Glenmark Pharma’s subsidiary Glenmark Specialty, has entered into an exclusive licensing agreement with Australia’s Seqirus to commercialize its nasal spray, Ryaltris in Australia and New...